We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
136 hedge funds and large institutions have $1.01B invested in Madrigal Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 52 increasing their positions, 46 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
464% more call options, than puts
Call options by funds: $96.1M | Put options by funds: $17M
13% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 46
2.2% more ownership
Funds ownership: 56.15% → 58.36% (+2.2%)
13% less funds holding
Funds holding: 156 → 136 (-20)
45% less capital invested
Capital invested by funds: $1.85B → $1.01B (-$835M)
48% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 42
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
136
Holders Change
-20
Holders Change %
-12.82%
% of All Funds
3.03%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
22
Increased
52
Reduced
46
Closed
42
Calls
$96.1M
Puts
$17M
Net Calls
+$79.1M
Net Calls Change
+$2.42M
Top Buyers
| 1 |
HM
HealthCor Management
New York
|
+$65.9M |
| 2 |
JP Morgan Chase
New York
|
+$60.2M |
| 3 |
State Street
Boston,
Massachusetts
|
+$26.6M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$14.5M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$13M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$37.1M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
-$36.8M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$28M |
| 4 |
O
OppenheimerFunds
New York
|
-$20.5M |
| 5 |
AC
Armistice Capital
New York
|
-$17.1M |
